Researchers work to make blood cancer a manageable illness with mutation identification

As blood cancers are constantly evolving and developing mutations that grow resistance to current treatments, researchers in the University of Cincinnati Cancer Center’s Leukemia and Drug Development Lab (LDDL) are constantly working to bring new treatments to patients.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup